Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:23:12.989Z.
Calculation as of: 2026-10-06T21:23:12.989Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4fd5d7af3ee6af72921bc315e5ba82b5757c441ca2a41ed9c1ba6c6f3afb8810
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Regencell Bioscience Holdings Limited
Market Cap
$3.64B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.57B
EV/FCF Ratio
N/A
TTM Avg
14.36x
3Y Avg
14.36x
5Y Avg
14.36x
Market Cap
$3.52B
EV/FCF Ratio
102.71x
TTM Avg
176.05x
3Y Avg
209.85x
5Y Avg
209.85x
Market Cap
$3.48B
EV/FCF Ratio
N/A
TTM Avg
10.34x
3Y Avg
10.32x
5Y Avg
10.32x
Market Cap
$3.38B
EV/FCF Ratio
17.60x
TTM Avg
24.95x
3Y Avg
51.13x
5Y Avg
51.13x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.64B | N/A | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | N/A | 14.36x | 14.36x | 14.36x |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 19.97x | 25.47x | 39.59x | 56.23x |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 102.71x | 176.05x | 209.85x | 209.85x |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | N/A | 10.34x | 10.32x | 10.32x |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 17.60x | 24.95x | 51.13x | 51.13x |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
